We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6674:TSEGS Yuasa Corporation Analysis

Data as of 2026-08-25 - not real-time

¥5,357.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

GS Yuasa Corporation trades at ¥5,357.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 13.3%. RSI sits at 43.5, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at ¥5,044.00 and resistance at ¥6,314.00.
Valuation screens as undervalued, on a P/E of 17.1 with no clean sector comparison available. The average analyst target implies 34.8% above today's level. Revenue is growing at 7.5%. The 1.82% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 59.5%, a beta of 0.78 and a maximum drawdown of 31.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

Detailed price information for GS Yuasa Corp Ord GYUAF from The Globe and Mail including charting and trades.MarketWatch20dGS Yuasa Corp 1Q Net Y7.56B Vs Net Y6.53BGS Yuasa Corp. 6674.TO Japan 1st Quarter Ended June 30 GROUP...Investing10yGS Yuasa Corp. 6674 6674 News Find the latest GS Yuasa Corp. news today, including breaking GS Yuasa Corp....

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 5227.65
  • MACD momentum is positive
  • 30-day price change of -13.3%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 5227.65
  • Analyst targets imply +34.8% versus the current price
  • 30-day volatility of 59.5%

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +34.8% versus the current price
  • P/E ratio of 17.1
  • 30-day volatility of 59.5%

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
P/E Ratio17.1
ROE11.98%
ROA5.57%
Debt/Equity30.93
P/B Ratio1.4

Technical Analysis

TrendNeutral
RSI43.5
Support¥5,044.00
Resistance¥6,314.00
MA 20¥5,454.00
MA 50¥6,035.78
MA 200¥5,227.65
MACDBullish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Target Price¥7,222.22
Upside/Downside34.82%
GradeUndervalued
TypeBlend
Dividend Yield1.82%

Risk Assessment

Beta0.78
Volatility59.45%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.